Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas : pretherapeutic study with dose recovery in resected tissues

Article de revue

M Ychou, M Ricard, C Parmentier, J Lumbroso, P Rougier, J.-P Mach, F Buchegger, J.-C Saccavini, P Lasser, D Elias, …

European journal of cancer. Part A, Vol.29(8), pp.1105-1111

1993

Résumé

Antineoplastic agents

Biological and medical sciences

Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Medical sciences

Pharmacology. Drug treatments

1 Consultations de la notice

Titre: Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas : pretherapeutic study with dose recovery in resected tissues
Créateurs - sans rôle: M Ychou - Cent. Val d'Aurelle, 34094 Montpellier, France
M Ricard - INSERM, inst. Gustave-Roussy, U66, 94805 Villejuif, France
C Parmentier - INSERM, inst. Gustave-Roussy, U66, 94805 Villejuif, France
J Lumbroso - INSERM, inst. Gustave-Roussy, U66, 94805 Villejuif, France
P Rougier - Inst. Gustave Roussy, 94805 Villejuif, France
J.-P Mach - Cent. Val d'Aurelle, 34094 Montpellier, France
F Buchegger - Cent. Val d'Aurelle, 34094 Montpellier, France
J.-C Saccavini - Cent. Val d'Aurelle, 34094 Montpellier, France
P Lasser - Inst. Gustave Roussy, 94805 Villejuif, France
D Elias - Inst. Gustave Roussy, 94805 Villejuif, France
F Eschwege - Inst. Gustave Roussy, 94805 Villejuif, France
Détails de publication: European journal of cancer. Part A, Vol.29(8), pp.1105-1111
Éditeur: Pergamon Press
Identifiants: 99140129009311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article